Ceftazidime therapy of serious bacterial infections.

Ceftazidime, a new broad-spectrum cephalosporin, was administered to 30 patients with serious bacterial infections in a randomized dosing trial with daily doses of 1.5 or 3 g. Both regimens were equally efficacious, with satisfactory clinical responses in 28 instances (93%) and microbiological eradi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Eron, L J, Goldenberg, R I, Park, C H, Poretz, D M
Format: Artigo
Sprog:Inglês
Udgivet: 1983
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC186028/
https://ncbi.nlm.nih.gov/pubmed/6340601
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker